Patients with pulmonary hypertension usually do not have a significant effect when taking beprostadine sodium tablets. Beprostadine sodium is usually used as an anti-thrombotic drug for improving symptoms such as ulcer disease, intermittent claudication, pain or peripheral neuritis caused by chronic arterial occlusion, and the main component is beprostadine sodium, which patients can use to improve a range of comorbidities caused by arterial thromboembolic disease. Therefore, for patients with pulmonary hypertension, taking Beprostone sodium usually does not have significant therapeutic effects and is prone to adverse reactions, such as inducing bleeding tendencies and, in severe cases, interstitial pneumonia, abnormal lung function, and abnormal liver function.